Teviah E. Sachs

Teviah E. Sachs

Auto-generated profile, based on publicly available information

Teviah E. Sachs

Department of Surgery, Boston Medical Center, Boston, Massachusetts; Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
BBBarbara Aldana Blanco
Barbara Aldana Blanco
MPMichael Poulson
Michael Poulson
KKKelly M. Kenzik
Kelly M. Kenzik
DMDavid B. McAneny
David B. McAneny
JTJennifer F. Tseng
Jennifer F. Tseng
TSTeviah E. Sachs
Teviah E. Sachs

1 May 2015 in Journal of Surgical Research
Verified
Journal Article
Closed access
TSTeviah E. Sachs
Teviah E. Sachs
TPTimothy M. Pawlik
Timothy M. Pawlik

6 July 2022 in Annals of Surgery
Verified
Journal Article
Closed access
MPMarianna V. Papageorge
Marianna V. Papageorge
AWAlison P. Woods
Alison P. Woods
SGSusanna W.L. de Geus
Susanna W.L. de Geus
SNSing Chau Ng
Sing Chau Ng
DMDavid McAneny
David McAneny
TSTeviah E. Sachs
Teviah E. Sachs
Objective: To determine the effect of persistent poverty on the diagnosis, surgical resection and survival of patients with non–small cell lung (NSCLC), breast, and colorectal cancer. Background: Disparities in cancer outcomes exist in counties with high levels of poverty, defined as ≥20% of residents below the federal poverty level. Despite this well-established association, little is known about how the duration of poverty impacts cancer care and outcomes. One measure of poverty duration is that of “persistent poverty,” defined as counties in high poverty since 1980. Methods: In this retrospective cohort study, patients with NSCLC, breast and colorectal cancer were identified from SEER (2012–2016). County-level poverty was obtained from the American Community Survey (1980–2015). Outcomes included advanced stage at diagnosis (stage III–IV), resection of localized disease (stage I–II) and cancer-specific survival. Hierarchical generalized linear models and accelerated failure time models with Weibull distribution were used, adjusted for patient-level covariates and region. Results: Overall, 522,514 patients were identified, of which 5.1% were in persistent poverty. Patients in persistent poverty were more likely to present with advanced disease [NSCLC odds ratio (OR): 1.12, 95% confidence interval (CI): 1.06–1.18; breast OR: 1.09, 95% CI: 1.02–1.17; colorectal OR: 1.00, 95% CI: 0.94–1.06], less likely to undergo surgery (NSCLC OR: 0.81, 95% CI: 0.73–0.90; breast OR: 0.82, 95% CI: 0.72–0.94; colorectal OR: 0.84, 95% CI: 0.70–1.00) and had increased cancer-specific mortality (NSCLC HR: 1.09, 95% CI: 1.06–1.13; breast HR: 1.18, 95% CI: 1.05–1.32; colorectal HR: 1.09, 95% CI: 1.03–1.17) as compared with those without poverty. These differences were observed to a lesser magnitude in counties with current, but not persistent, poverty and disappeared in counties no longer in poverty. Conclusions: The duration of poverty has a direct impact on cancer-specific outcomes, with the greatest effect seen in persistent poverty and resolution of disparities when a county is no longer in poverty. Policy focused on directing resources to communities in persistent poverty may represent a possible strategy to reduce disparities in cancer care and outcomes.

15 July 2022 in Annals of Surgery
Verified
Journal Article
Closed access
MPMichael R. Poulson
Michael R. Poulson
MPMarianna V. Papageorge
Marianna V. Papageorge
ALAlexander S. BS LaRaja
Alexander S. BS LaRaja
KKKelly M. Kenzik
Kelly M. Kenzik
TSTeviah E. Sachs
Teviah E. Sachs
Objective: To understand the mediating effect of socioeconomic factors on the association between residential segregation and racial disparities in pancreatic cancer (PC). Background: Black patients with PC present at a later stage and have worse mortality than White patients. These disparities have been explained by the level of residential segregation. Methods: Data were obtained from Surveillance, Epidemiology, and End-Results (SEER) and included all Black and White patients who were diagnosed with PC between 2005 and 2015. The primary exposure variable was the Index of Dissimilarity, a validated measure of segregation. County-level socioeconomic variables from the US Census were assessed as mediators. The primary outcomes were advanced stage at diagnosis, surgical resection for localized disease, and overall mortality. Generalized structural equation modeling was used to assess the mediation of each of the socioeconomic variables. Results: Black patients in the highest levels of segregation saw a 12% increased risk [relative risk=1.12; 95% confidence interval (CI): 1.08, 1.15] of presenting at an advanced stage, 11% decreased likelihood of undergoing surgery (relative risk=0.89; 95% CI: 0.83, 0.94), and 8% increased hazards of death (hazard ratio=1.08; 95% CI: 1.03, 1.14) compared with White patients in the lowest levels. The Black share of the population, insurance status, and income inequality mediated 58% of the total effect on the advanced stage. Poverty and Black income immobility mediated 51% of the total effect on surgical resection. Poverty and Black income immobility mediated 50% of the total effect on overall survival. Conclusions: These socioeconomic factors serve as intervention points for legislators to address the social determinants inherent to the structural racism that mediate poor outcomes for Black patients.

1 October 2019 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PSPraveen Sridhar
Praveen Sridhar
PMPriya Misir
Priya Misir
HKHyunjee Kwak
Hyunjee Kwak
SDSusanna Wl. Degeus
Susanna Wl. Degeus
FDFrederick T. Drake
Frederick T. Drake
TSTeviah E. Sachs
Teviah E. Sachs
Social determinants of health impact the delivery of care and outcomes in patients with pancreatic cancer. We explored the relationship between social determinants of health and presentation, treatment, and outcomes of patients with pancreatic adenocarcinoma at an urban safety-net medical center. A single-institution retrospective chart review of patients with pancreatic adenocarcinoma was conducted. Demographic, tumor, and treatment characteristics were obtained. Median overall survival, stage-specific survival, receipt of curative operation, and receipt of perioperative therapy were analyzed. Chi-square tests were used for categorical variables. Survival was determined by the Kaplan-Meier method. We identified 240 patients with pancreatic adenocarcinoma treated between January 2006 and December 2017. Median age was 66 years, 51% were female, 48% were non-white, 22% were non-English-speaking, 16% were Hispanic, and 40% were Medicaid/uninsured. There were 74 (31%) patients with early-stage (I/II) disease. There were no statistically significant differences between race, primary language, or ethnicity and receipt of surgical therapy or receipt of perioperative therapy. Relatively more patients with private insurance (100%) received perioperative therapy compared with Medicaid/uninsured (64%) and Medicare-insured (50%) patients (p = 0.018). Nearly 30% of patients with operable disease either declined having an intervention or were found to be too frail to undergo surgical intervention. There were no statistically significant relationships between examined social determinants of health and use of operation or perioperative therapy. Patients treated at an urban safety-net hospital with a focus on vulnerable patient populations are able to provide outcomes similar to national averages. Additional exploration of factors affecting outcomes for pancreatic cancer in these patients will be important, as many centers absorb higher immigrant and indigent populations.

19 January 2021 in HPB
Verified
Journal Article
Closed access
MPMichael R. Poulson
Michael R. Poulson
BBB. Aldana Blanco
B. Aldana Blanco
AGAlaina D. Geary
Alaina D. Geary
KKKelly M. Kenzik
Kelly M. Kenzik
DMDavid B. McAneny
David B. McAneny
TSTeviah E. Sachs
Teviah E. Sachs